MOGRAA
[ Pharmaceutical preparations for modification of the function of g-protein-coupled receptors, consisting of monoclonal antibody; pharmaceutical preparations for the treatment and prevention of obesity, diabetes, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases and pain; antibodies for medical purposes; reagent paper for medical purposes ]
Registered · August 29, 2016 · 79198394 ·